4.4 Review

Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications

Journal

SURGICAL ONCOLOGY-OXFORD
Volume 10, Issue 1-2, Pages 1-23

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S0960-7404(01)00016-0

Keywords

pancreatic cancer; hereditary pancreatitis; pathogenesis; screening; treatment

Ask authors/readers for more resources

Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer death worldwide. PDAC is also one of the best-studied cancers with regard to molecular pathogenesis. The chief risk factors associated with PDAC are smoking and pancreatitis, in addition genetic predisposition seems to play a major role. This genetic predisposition may in some cases be indirect, for example via the elevated risk of pancreatitis seen in patients with hereditary pancreatitis (HP). The elucidation of the molecular causes of PDAC has enabled the provision of secondary screening for PDAC in conditions such as HP. This review is concerned with the molecular pathogenesis of PDAC and the application of this basic scientific understanding into state-of-the-art clinical practice. (C) 2001 Elsevier Science Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available